The Latest
State ActionCCAGW Urges South Dakota Senators to Oppose SB 154
Senate Bill 154 would change how the federal 340B Drug Pricing Program operates in South Dakota.
Press ReleaseCitizens Against Government Waste Releases Issue Brief on Federal Budget Reform
The congressional budget process has been an abject failure and is long overdue for reform.
Letters to OfficialsCCAGW Joins Coalition Opposing Medicare Drug Price Negotiation Program
Drug price controls have caused premiums to increase and options to decrease for seniors in Medicare Part D.
The WasteWatcherThe Savings from Broadband Bulk Billing Are Saved
A Biden-era effort to ban cost-saving bulk billing of internet services has been halted by new FCC Chairman Brendan Carr.
Letters to OfficialsCCAGW Joins Coalition Opposing Credit Card Competition Act
Price controls on interchange fees or interest rates are diametrically opposed to free market principles.
Press ReleaseCitizens Against Government Waste Names CFPB Director Rohit Chopra January 2025 Porker of the Month
CFPB Director Rohit Chopra is our January 2025 Porker of the Month for abusing his power and failing to protect consumers.
State ActionCCAGW Urges Kentucky Senators to Oppose SB 14
Senate Bill 14 will change how the federal 340B Drug Pricing Program operates in the Bluegrass State.
The WasteWatcherPresident Trump Saves Money Just By Creating DOGE
President Trump takes steps to improve government programs by transforming USDS into U.S. DOGE Service.
The WasteWatcherNavy and Congress Share Blame for Ship Modernization Waste
The Navy wasted nearly half of the money spent on modernizing seven cruisers; members of Congress are also to blame.
Letters to OfficialsCCAGW Joins Coalition Urging Congress to Oppose Efforts to Raise Corporate Tax Rate
The lower corporate tax rate in the TCJA is working and Congress should not increase it.
State ActionCCAGW Urges Indiana Legislators to Oppose Senate Bill 140
SB 140 would impose onerous regulations on pharmacy benefit managers.
The WasteWatcherHospitals Abuse 340B Program at the Expense of Vulnerable Patients
The 340B Drug Pricing Program allows hospitals to prioritize profits over patients.
